Chenji Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- Cancer-related molecular mechanisms research 8
- Cell Biology 16
Chenji Wang
79 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 595
- Molecular Biology 1.5k
- Cell Biology 280
- Oncology 379
- Pulmonary and Respiratory Medicine 406
Countries citing papers authored by Chenji Wang
This map shows the geographic impact of Chenji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenji Wang more than expected).
Fields of papers citing papers by Chenji Wang
This network shows the impact of papers produced by Chenji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenji Wang. The network helps show where Chenji Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chenji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 26 | |
| 9 | 2023 | 66 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 3 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 13 | |
| 14 | Development of dual delivery antituberculotic system containing rifapentine microspheres and adipose stem cells seeded in hydroxyapatite/tricalcium phosphate | 2019 | 1 |
| 15 | 2017 | 55 | |
| 16 | 2015 | 20 | |
| 17 | 2015 | 35 | |
| 18 | 2015 | 63 | |
| 19 | 2012 | 34 | |
| 20 | 2007 | 10 |
About Chenji Wang
Chenji Wang is a scholar working on Cancer Research, Cell Biology, Molecular Biology, Physiology and Biochemistry, having authored 85 papers that have together received 2.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (28 papers), RNA modifications and cancer (11 papers), Cancer-related Molecular Pathways (9 papers), Cancer-related gene regulation (9 papers), Cancer-related molecular mechanisms research (8 papers), Prostate Cancer Treatment and Research (8 papers), Autophagy in Disease and Therapy (7 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Cancer Research (595 citations), Molecular Biology (1.5k citations), Cell Biology (280 citations), Oncology (379 citations) and Pulmonary and Respiratory Medicine (406 citations). Chenji Wang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Long Yu, Pingzhao Zhang, Haojie Huang, Kun Gao, Jian An, Yibin Deng, Minghua Wang, Jiucun Wang, Yinghui Zhou and Shicheng Guo. Their work appears in journals such as Cell Death and Differentiation, Cancer Letters, Cell Death and Disease, Autophagy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.